In summary, as depicted in Fig. 9, this study demonstrated that the downregulation of PDLIM2 leads to heightened NF-κB activity in lung cancer cells, thereby dysregulating SDH gene expression and mitochondrial functions. This evidence concerns the gene PDLIM2 and lung carcinoma.